{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:08:01Z","timestamp":1780564081028,"version":"3.54.1"},"reference-count":61,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Tertiary hyperparathyroidism (THPT) arises in patients with chronic kidney disease (CKD) as a consequence of prolonged secondary hyperparathyroidism and is marked by autonomous parathyroid hormone (PTH) secretion. In some cases, parathyroid hyperplasia persists even after successful renal transplantation, resulting in sustained PTH elevation and hypercalcaemia. These alterations contribute to bone loss, vascular calcification, and increased cardiovascular risk. Management includes medical therapy with calcimimetics or vitamin D analogues and surgical intervention via parathyroidectomy. However, optimal timing and treatment strategy remain uncertain. This review examines the pathophysiology, clinical manifestations, and current management paradigms of THPT, with an emphasis on areas that require further research and consensus.<\/jats:p>","DOI":"10.3390\/biomedicines13112604","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:31:58Z","timestamp":1761550318000},"page":"2604","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tertiary Hyperparathyroidism in Diabetic Nephropathy: An Underrecognized Complication\u2014A Narrative Review"],"prefix":"10.3390","volume":"13","author":[{"given":"Mirona","family":"Costea","sequence":"first","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 020021 Bucharest, Romania"},{"name":"Endocrinology Department, Bucharest University Emergency Hospital, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5655-2694","authenticated-orcid":false,"given":"Dana-Mihaela","family":"Tilici","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 020021 Bucharest, Romania"},{"name":"Endocrinology Department, Bucharest University Emergency Hospital, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Loreta","family":"Paun","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Bucharest University Emergency Hospital, 050098 Bucharest, Romania"},{"name":"Faculty of Medicine, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda Roxana","family":"Nimigean","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 020021 Bucharest, Romania"},{"name":"Department of Oral Rehabilitation, Faculty of Dentistry, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8301-4131","authenticated-orcid":false,"given":"Sorin Constantin","family":"Paun","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 020021 Bucharest, Romania"},{"name":"Bucharest Emergency Clinical Hospital, Calea Floreasca 8, 014461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rucsandra Elena","family":"Danciulescu-Miulescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Medicine and Pharmacy \u201cCarol Davila\u201d, 020021 Bucharest, Romania"},{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tilici, D.M., Paun, D.L., Arnautu, A.M., Mirica, A., Duta, C., Costea, M., and Guja, C. (2025). The Intricate Relationship Between Thyroid Disorders and Type 2 Diabetes\u2014A Narrative Review. Diabetology, 6.","DOI":"10.20944\/preprints202504.0802.v1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"119635","DOI":"10.1016\/j.lfs.2021.119635","article-title":"Diabetic nephropathy: A twisted thread to unravel","volume":"278","author":"Dagar","year":"2021","journal-title":"Life Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14791641211058856","DOI":"10.1177\/14791641211058856","article-title":"Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature","volume":"18","author":"Thipsawat","year":"2021","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.pathol.4.110807.092150","article-title":"A glimpse of various pathogenetic mechanisms of diabetic nephropathy","volume":"6","author":"Kanwar","year":"2011","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"119762","DOI":"10.1016\/j.cca.2024.119762","article-title":"Urinary biomarkers in diabetic nephropathy","volume":"561","author":"Taghvimi","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"ref_7","first-page":"7","article-title":"Diabetic Nephropathy: Pathogenesis, Mechanisms, and Therapeutic Strategies","volume":"57","author":"Dwivedi","year":"2024","journal-title":"Horm. Metab. Res."},{"key":"ref_8","unstructured":"Dr\u00fceke, T.B. (2025, July 08). Hyperparathyroidism in Chronic Kidney Disease. Endotext, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK278975\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000346791","article-title":"Parathyroid function in chronic kidney disease: Role of FGF23-klotho axis","volume":"180","author":"Koizumi","year":"2013","journal-title":"Contrib. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5005\/jp-journals-10088-11184","article-title":"The Panorama of Hyperparathyroidism","volume":"17","author":"Gupta","year":"2022","journal-title":"Indian J. Endocr. Surg. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/ckj\/sfab006","article-title":"Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease","volume":"14","author":"Xu","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ando.2022.05.003","article-title":"Calcium homeostasis and hyperparathyroidism: Nephrologic and endocrinologic points of view","volume":"83","author":"Lemoine","year":"2022","journal-title":"Ann. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1067\/msy.2000.108117","article-title":"A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism","volume":"128","author":"Pasieka","year":"2000","journal-title":"Surgery"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Leeds, J., and Doyle, A. (2025). Tertiary Hyperparathyroidism. Medical and Surgical Treatment of Parathyroid Diseases, Springer.","DOI":"10.1007\/978-3-031-81813-4_7"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hu, L., Napoletano, A., Provenzano, M., Garofalo, C., Bini, C., Comai, G., and La Manna, G. (2022). Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012223"},{"key":"ref_16","first-page":"241","article-title":"Tertiary hyperparathyroidism: A review","volume":"172","author":"Palumbo","year":"2021","journal-title":"Clin. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.surg.2021.03.067","article-title":"Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients","volume":"171","author":"Sutton","year":"2022","journal-title":"Surgery"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/bjs.10554","article-title":"Systematic review of surgical and medical treatment for tertiary hyperparathyroidism","volume":"104","author":"Dulfer","year":"2017","journal-title":"Br. J. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.transproceed.2005.12.065","article-title":"Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients","volume":"38","author":"Afsar","year":"2006","journal-title":"Transplant. Proc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-0012.2007.00690.x","article-title":"Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure","volume":"21","author":"Egbuna","year":"2007","journal-title":"Clin. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5603\/rdatf.96819","article-title":"Management of chronic kidney disease\u2013mineral and bone disorder","volume":"16","author":"Hryciuk","year":"2023","journal-title":"Ren. Dis. Transplant. Forum"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1457496919866015","article-title":"Secondary and Tertiary Hyperparathyroidism: A Narrative Review","volume":"109","author":"Noltes","year":"2020","journal-title":"Scand. J. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00223-021-00874-9","article-title":"Bone Histomorphometry and 18F-Sodium Fluoride Positron Emission Tomography Imaging: Comparison Between only Bone Turnover-based and Unified TMV-based Classification of Renal Osteodystrophy","volume":"109","author":"Aaltonen","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Aguilar, A., Gifre, L., Ure\u00f1a-Torres, P., Carrillo-L\u00f3pez, N., Rodriguez-Garc\u00eda, M., Mass\u00f3, E., da Silva, I., L\u00f3pez-B\u00e1ez, V., S\u00e1nchez-Bay\u00e1, M., and Prior-Espa\u00f1ol, \u00c1. (2023). Pathophysiology of bone disease in chronic kidney disease: From basics to renal osteodystrophy and osteoporosis. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1177829"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/j.ajkd.2020.12.024","article-title":"Osteoporosis and Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD): Back to Basics","volume":"78","author":"Pazianas","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5301\/jn.5000212","article-title":"Osteoporosis and adynamic bone in chronic kidney disease","volume":"26","author":"Alonso","year":"2013","journal-title":"J. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00223-020-00777-1","article-title":"Chronic Kidney Disease\u2014Mineral and Bone Disorders: Pathogenesis and Management","volume":"108","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10157-016-1368-3","article-title":"Chronic kidney disease and fragility fracture","volume":"21","author":"Kazama","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_29","unstructured":"Shah, A., Hashmi, M.F., and Aeddula, N.R. (2025, August 19). Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD). StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560742\/."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41581-023-00736-7","article-title":"Inflammation and gut dysbiosis as drivers of CKD\u2013MBD","volume":"19","author":"Evenepoel","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: A review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/nep.14407","article-title":"Phosphorous metabolism and manipulation in chronic kidney disease","volume":"29","author":"Marando","year":"2024","journal-title":"Nephrology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJNRD.S78040","article-title":"Phosphate binders for the treatment of chronic kidney disease: Role of iron oxyhydroxide","volume":"9","author":"Cernaro","year":"2016","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1345\/aph.1M291","article-title":"Sevelamer Carbonate","volume":"44","author":"Barna","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40265-014-0215-7","article-title":"Sevelamer Carbonate: A Review in Hyperphosphataemia in Adults with Chronic Kidney Disease","volume":"74","author":"Perry","year":"2014","journal-title":"Drugs"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4070\/kcj.2021.0995","article-title":"Vascular calcification in chronic kidney disease: Distinct features of pathogenesis and clinical implication","volume":"51","author":"Kim","year":"2021","journal-title":"Korean Circ. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nefro.2017.05.012","article-title":"Changes in renal function after discontinuation of vitamin D analogues in advanced chronic kidney disease","volume":"38","author":"Caravaca","year":"2018","journal-title":"Nefrolog\u00eda"},{"key":"ref_38","first-page":"100238","article-title":"Secondary hyperparathyroidism in chronic kidney disease: A narrative review focus on therapeutic strategy","volume":"24","author":"Tsai","year":"2024","journal-title":"Clin. Med. J. R. Coll. Physicians Lond."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Patel, R., Kharkwal, H., Saha, M., Sankaranarayanan, M., Sharma, S., and Chander, S. (2025). Recent Advancements Towards the Use of Vitamin D Isoforms and the Development of Their Synthetic Analogues as New Therapeutics. Biomedicines, 13.","DOI":"10.3390\/biomedicines13041002"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11255-019-02088-3","article-title":"Vitamin D supplementation for the improvement of vascular function in patients with chronic kidney disease: A meta-analysis of randomized controlled trials","volume":"51","author":"Dou","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"E1424","DOI":"10.1210\/clinem\/dgad289","article-title":"Paricalcitol and Extended-Release Calcifediol for Treatment of Secondary Hyperparathyroidism in Non-Dialysis Chronic Kidney Disease: Results From a Network Meta-Analysis","volume":"108","author":"Franchi","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.numecd.2023.09.015","article-title":"Effect of regulated vitamin D increase on vascular markers in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Pan","year":"2024","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/1744-9987.14125","article-title":"Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies","volume":"28","author":"Nakai","year":"2024","journal-title":"Ther. Apher. Dial."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Li, X., Ding, W., and Zhang, H. (2023). Cinacalcet use in secondary hyperparathyroidism: A machine learning-based systematic review. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1146955"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11914-023-00782-x","article-title":"Impact of Cinacalcet and Etelcalcetide on Bone Mineral and Cardiovascular Disease in Dialysis Patients","volume":"21","author":"Bernardor","year":"2023","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.ekir.2023.08.034","article-title":"Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism","volume":"8","author":"Ni","year":"2023","journal-title":"Kidney Int. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/ckj\/sfx125","article-title":"Old and new calcimimetics for treatment of secondary hyperparathyroidism: Impact on biochemical and relevant clinical outcomes","volume":"11","author":"Pereira","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nefro.2024.09.004","article-title":"Etelcalcetide: What we know eight years since its approval","volume":"45","author":"Freitas","year":"2025","journal-title":"Nefrologia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MNH.0000000000000799","article-title":"Lessons from effect of etelcalcetide on left ventricular hypertrophy in patients with end-stage kidney disease","volume":"31","author":"Kainz","year":"2022","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s40265-021-01578-y","article-title":"Upacicalcet: First Approval","volume":"81","author":"Hoy","year":"2021","journal-title":"Drugs"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.0000000000000253","article-title":"Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism A Randomized Placebo-Controlled Trial","volume":"18","author":"Shigematsu","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Casella, C., Guarneri, C., Campanile, M., Adhoute, X., Gelera, P.P., and Morandi, R. (2023). Surgical treatment of tertiary hyperparathyroidism: Does one fit for all?. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1226917"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jss.2015.04.046","article-title":"Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism","volume":"199","author":"Oltmann","year":"2015","journal-title":"J. Surg. Res."},{"key":"ref_55","first-page":"104609","article-title":"Intraoperative parathyroid hormone monitoring in parathyroidectomy: Predicting cure and recurrence in tertiary hyperparathyroidism\u2014Systematic review","volume":"46","author":"Finnegan","year":"2025","journal-title":"Am. J. Otolaryngol. Head Neck Med. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Zhang, L.X., Zhang, B., Liu, X.-Y., Wang, Z.-M., Qi, P., Zhang, T.-Y., and Zhang, Q. (2022). Advances in the treatment of secondary and tertiary hyperparathyroidism. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1059828"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.amjsurg.2022.05.002","article-title":"Is preoperative parathyroid localization necessary for tertiary hyperparathyroidism?","volume":"224","author":"Wang","year":"2022","journal-title":"Am. J. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Rao, S.S., Rao, H., Moinuddin, Z., Rozario, A.P., and Augustine, T. (2023). Preservation of parathyroid glands during thyroid and neck surgery. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1173950"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/IJNRD.S47179","article-title":"Incidence of and risk factors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism","volume":"6","author":"Latus","year":"2013","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Tan, Z.K., Looi, W.L., Chen, F., Yeo, S.C., and Bairy, M. (2025). Determinants of Severe Hypocalcemia After Parathyroidectomy in Patients with End-Stage Kidney Disease and Renal Hyperparathyroidism: A Retrospective Cohort Study. J. Clin. Med., 14.","DOI":"10.3390\/jcm14020379"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.15537\/smj.2024.45.12.20240743","article-title":"Post-thyroidectomy hypoparathyroidism: A clinical surgical dilemma","volume":"45","author":"Alqahtani","year":"2024","journal-title":"Saudi Med. J."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/11\/2604\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:04:57Z","timestamp":1761552297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/11\/2604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":61,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["biomedicines13112604"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13112604","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}